In Vivo Effects of Prostaglandin Analogues Application by Topical Drops or Retrobulbar Injections on the Orbital Fat of a Rat Model

References

• Brubaker RF. Mechanism of action of bimatoprost (Lumigan™). Surv Ophthalmol. 2001 May 1;45:S347–51. doi:10.1016/S0039-6257(01)00213-2.
   PubMed Web of Science ®Google Scholar
• Parrish RK, Palmberg P, Sheu WP. XLT study group. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure:: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol. 2003 May 1;135(5):688–703. doi:10.1016/S0002-9394(03)00098-9.
   PubMed Web of Science ®Google Scholar
• Vogel R, Strahlman E, Rittenhouse KD. Adverse events associated with commonly used glaucoma drugs. Int Ophthalmol Clin. 1999 Apr 1;39(2):107–124. doi:10.1097/00004397-199903920-00009.
   PubMedGoogle Scholar
• Filippopoulos T, Paula JS, Torun N, Hatton MP, Pasquale LR, Grosskreutz CL. Periorbital changes associated with topical bimatoprost. Ophthalmic Plast Reconstr Surg. 2008 Jul 1;24(4):302–307. doi:10.1097/IOP.0b013e31817d81df.
   PubMed Web of Science ®Google Scholar
• Holló G. The side effects of the prostaglandin analogues. Expert Opin Drug Saf. 2007 Jan 1;6(1):45–52. doi:10.1517/14740338.6.1.45.
   PubMed Web of Science ®Google Scholar
• WebSite-FDA. Pharmacology review travoprost (Alcon). P1.pdf. Accessed August 16, 2007.
   Google Scholar
• WebSite-FDA. Pharmacology review bimatoprost (Allergan). P2.pdf. Accessed August 17, 2007.
   Google Scholar
• Lee SS, Almazan A, Decker S, et al. Intraocular pressure effects and mechanism of action of topical versus sustained-release bimatoprost. Trans Vision Sci Technol. 2019 Jan 2;8(1):15. doi:10.1167/tvst.8.1.15.
   PubMed Web of Science ®Google Scholar
• Serrero G, Lepak NM. Prostaglandin F2alpha receptor (FP receptor) agonists are potent adipose differentiation inhibitors for primary culture of adipocyte precursors in defined medium. Biochem Biophys Res Commun. 1997 Apr 7;233(1):200–202. doi:10.1006/bbrc.1997.6433.
   PubMed Web of Science ®Google Scholar
• Reginato MJ, Krakow SL, Bailey ST, Lazar MA. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor γ. J Biol Chem. 1998 Jan 23;273(4):1855–1858. doi:10.1074/jbc.273.4.1855.
   PubMed Web of Science ®Google Scholar
• Taketani Y, Yamagishi R, Fujishiro T, Igarashi M, Sakata R, Aihara M. Activation of the prostanoid FP receptor inhibits adipogenesis leading to deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy. Invest Ophthalmol Vis Sci. 2014 Mar 1;55(3):1269–1276. doi:10.1167/iovs.13-12589.
   PubMed Web of Science ®Google Scholar
• Choi CJ, Tao W, Doddapaneni R, et al. The effect of prostaglandin analogue bimatoprost on thyroid-associated orbitopathy. Invest Ophthalmol Vis Sci. 2018 Dec 3;59(15):5912–5923. doi:10.1167/iovs.18-25134.
   PubMed Web of Science ®Google Scholar
• Kim HW, Choi YJ, Lee KW, Lee MJ. Periorbital changes associated with prostaglandin analogs in Korean patients. BMC Ophthalmol. 2017 Dec;17(1):1–7. doi:10.1186/s12886-017-0521-4.
   PubMedGoogle Scholar
• Chernick SS, Spooner PM, Garrison MM, Scow RO. Effect of epinephrine and other lipolytic agents on intracellular lipolysis and lipoprotein lipase activity in 3T3-L1 adipocytes. J Lipid Res. 1987 Jan 1;27(3):286–294. doi:10.1016/S0022-2275(20)38831-3.
   Web of Science ®Google Scholar
• Draman MS, Grennan-Jones F, Zhang L, et al. Effects of prostaglandin F2α on adipocyte biology relevant to Graves’ orbitopathy. Thyroid. 2013 Dec 1;23(12):1600–1608. doi:10.1089/thy.2013.0194.
   PubMed Web of Science ®Google Scholar
• Feingold KR, Doerrler WI, Dinarello CA, Fiers W, Grunfeld C. Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis. Endocrinology. 1992 Jan 1;130(1):10–16. doi:10.1210/endo.130.1.1370149.
   PubMed Web of Science ®Google Scholar
• Eftekhari K, Shindler KS, Lee V, Dine K, Eckstein LA, Reza VM. Histologic evidence of orbital inflammation from retrobulbar alcohol and chlorpromazine injection: a clinicopathologic study in human & rat orbits. Ophthalmic Plast Reconstr Surg. 2016 Jul;32(4):302. doi:10.1097/IOP.0000000000000512.
   PubMed Web of Science ®Google Scholar
• Eftekhari K, Vagefi MR, Lee V, et al. In vivo effects of retrobulbar bimatoprost injection on orbital fat. Ophthalmic Plast Reconstr Surg. 2018 May;34(3):201. doi:10.1097/IOP.0000000000000907.
   PubMed Web of Science ®Google Scholar
• Peplinski LS, Smith KA. Deepening of lid sulcus from topical bimatoprost therapy. Optometry Vision Sci. 2004 Aug 1;81(8):574–577. doi:10.1097/01.opx.0000141791.16683.4a.
   PubMed Web of Science ®Google Scholar
• Noma K, Kakizaki H. Bilateral upper eyelid retraction caused by topical bimatoprost therapy. <jtl>ophthalmic Plast Reconstr Surg. 2012 Mar 1;28(2):e33–5. doi:10.1097/IOP.0b013e31821639cc.
   PubMed Web of Science ®Google Scholar
• Park J, Cho HK, Moon JI. Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost. Jpn J Ophthalmol. 2011 Jan;55(1):22–27. doi:10.1007/s10384-010-0904-z.
   PubMed Web of Science ®Google Scholar
• Easthope SE, Perry CM. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension. Drugs Aging. 2002;19(3):231–248. doi:10.2165/00002512-200219030-00008.
   PubMed Web of Science ®Google Scholar
• Miyake K, Ibaraki N. Prostaglandins and cystoid macular edema. Surv Ophthalmol. 2002 Aug 1;47:S203–18. doi:10.1016/S0039-6257(02)00294-1.
   PubMed Web of Science ®Google Scholar
• Eiger-Moscovich M, Stiebel-Kalish H, Yassur I, Barash D, Gaton D, Avisar I. Prostaglandin analogue drops for the treatment of soft tissue expansion and exophthalmos in patients with inactive thyroid eye disease. Can J Ophthalmol. 2019 Aug 1;54(4):426–430. doi:10.1016/j.jcjo.2018.09.003.
   PubMed Web of Science ®Google Scholar
• Draman MS, Morris DS, Evans S, et al. Prostaglandin F2-alpha eye drops (bimatoprost) in graves’ orbitopathy: a randomized controlled double-masked crossover trial (BIMA Trial). Thyroid. 2019 Apr 1;29(4):563–572. doi:10.1089/thy.2018.0506.
   PubMed Web of Science ®Google Scholar